• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
β-Secretase: its biology as a therapeutic target in diseases.β-分泌酶:作为疾病治疗靶点的生物学特性。
Trends Pharmacol Sci. 2013 Apr;34(4):215-25. doi: 10.1016/j.tips.2013.01.008. Epub 2013 Feb 27.
2
Identification and biology of β-secretase.β-分泌酶的鉴定和生物学特性
J Neurochem. 2012 Jan;120 Suppl 1:55-61. doi: 10.1111/j.1471-4159.2011.07512.x. Epub 2011 Nov 28.
3
BACE1 structure and function in health and Alzheimer's disease.β-分泌酶1(BACE1)在健康与阿尔茨海默病中的结构与功能
Curr Alzheimer Res. 2008 Apr;5(2):100-20. doi: 10.2174/156720508783954758.
4
Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.BACE1 是否适合作为阿尔茨海默病治疗的靶点?当前策略和未来方向。
Biol Chem. 2010 Aug;391(8):849-59. doi: 10.1515/BC.2010.089.
5
The beta-secretase, BACE: a prime drug target for Alzheimer's disease.β-分泌酶,即β位点淀粉样前体蛋白裂解酶(BACE):阿尔茨海默病的主要药物靶点。
J Mol Neurosci. 2001 Oct;17(2):157-70. doi: 10.1385/JMN:17:2:157.
6
BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.β-分泌酶1切割位点的选择对淀粉样蛋白生成和阿尔茨海默病发病机制至关重要。
J Neurosci. 2017 Jul 19;37(29):6915-6925. doi: 10.1523/JNEUROSCI.0340-17.2017. Epub 2017 Jun 16.
7
Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.人类BACE2和BACE1基因独特的转录调控与功能
FASEB J. 2005 May;19(7):739-49. doi: 10.1096/fj.04-3426com.
8
The two-hydrophobic domain tertiary structure of reticulon proteins is critical for modulation of beta-secretase BACE1.网质蛋白的双疏水区三级结构对β-分泌酶 BACE1 的调节至关重要。
J Neurosci Res. 2009 Oct;87(13):2963-72. doi: 10.1002/jnr.22112.
9
BACE1 as a therapeutic target in Alzheimer's disease: rationale and current status.BACE1 作为阿尔茨海默病的治疗靶点:原理和现状。
Drugs Aging. 2013 Oct;30(10):755-64. doi: 10.1007/s40266-013-0099-3.
10
Ion channel regulation by β-secretase BACE1 - enzymatic and non-enzymatic effects beyond Alzheimer's disease.β-分泌酶BACE1对离子通道的调节——阿尔茨海默病之外的酶促和非酶促作用
Channels (Austin). 2016 Sep 2;10(5):365-378. doi: 10.1080/19336950.2016.1196307. Epub 2016 Jun 2.

引用本文的文献

1
Beta-Secretase 1 Recruits Amyloid-Beta Precursor Protein to ROCK2 Kinase, Resulting in Erroneous Phosphorylation and Beta-Amyloid Plaque Formation.β-分泌酶 1 将淀粉样前体蛋白募集到 ROCK2 激酶,导致错误磷酸化和β-淀粉样斑块形成。
Int J Mol Sci. 2023 Jun 21;24(13):10416. doi: 10.3390/ijms241310416.
2
New Insights into Alzheimer's Disease: Novel Pathogenesis, Drug Target and Delivery.阿尔茨海默病的新见解:新发病机制、药物靶点与递送
Pharmaceutics. 2023 Apr 3;15(4):1133. doi: 10.3390/pharmaceutics15041133.
3
Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.在链脲佐菌素诱导的高血糖大鼠模型中,抗糖尿病药物对阿尔茨海默病生物标志物的影响。
PLoS One. 2022 Jul 8;17(7):e0271138. doi: 10.1371/journal.pone.0271138. eCollection 2022.
4
BACE1: More than just a β-secretase.BACE1:不只是β-分泌酶。
Obes Rev. 2022 Jul;23(7):e13430. doi: 10.1111/obr.13430. Epub 2022 Feb 4.
5
Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model.基于生物学机制的神经学与精神病学:一种β-分泌酶1/2及下游通路模型
Curr Neuropharmacol. 2023;21(1):31-53. doi: 10.2174/1570159X19666211201095701.
6
Neuroactive venom compounds obtained from as potential leads for neurodegenerative diseases: insights on their acetylcholinesterase and beta-secretase inhibitory activities .从[来源]获得的神经活性毒液化合物作为神经退行性疾病的潜在先导物:对其乙酰胆碱酯酶和β-分泌酶抑制活性的见解 。 (注:原文中“from as potential leads for neurodegenerative diseases”里“from”后缺少具体来源信息,这里按字面翻译为“从[来源]” )
J Venom Anim Toxins Incl Trop Dis. 2021 Jun 28;27:e20210009. doi: 10.1590/1678-9199-JVATITD-2021-0009. eCollection 2021.
7
Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target.环境暴露与阿尔茨海默病的发病机制:BACE1 作为关键神经毒性靶点的潜在作用。
J Biochem Mol Toxicol. 2021 Apr;35(4):e22694. doi: 10.1002/jbt.22694. Epub 2021 Jan 4.
8
Progranulin Administration Attenuates β-Amyloid Deposition in the Hippocampus of 5xFAD Mice Through Modulating BACE1 Expression and Microglial Phagocytosis.通过调节β-分泌酶1(BACE1)的表达和小胶质细胞吞噬作用,给予前颗粒蛋白可减轻5xFAD小鼠海马中的β-淀粉样蛋白沉积。
Front Cell Neurosci. 2020 Aug 18;14:260. doi: 10.3389/fncel.2020.00260. eCollection 2020.
9
Potent -Glucosidase and -Secretase Inhibition of Amyrin-Type Triterpenoid Isolated from Linnaeus (Angel's Trumpet) Fruits.Linnaeus(天使之钟)果实中分离得到的桉叶烷型三萜的强效 -葡萄糖苷酶和 -分泌酶抑制作用。
Biomed Res Int. 2020 Aug 25;2020:8530165. doi: 10.1155/2020/8530165. eCollection 2020.
10
A Novel Compound YS-5-23 Exhibits Neuroprotective Effect by Reducing β-Site Amyloid Precursor Protein Cleaving Enzyme 1's Expression and HO-Induced Cytotoxicity in SH-SY5Y Cells.新型化合物YS-5-23通过降低β-位点淀粉样前体蛋白裂解酶1的表达及HO诱导的SH-SY5Y细胞毒性发挥神经保护作用。
Neurochem Res. 2020 Sep;45(9):2113-2127. doi: 10.1007/s11064-020-03073-4. Epub 2020 Jun 18.

本文引用的文献

1
Chronic administration of anti-stroke herbal medicine TongLuoJiuNao reduces amyloidogenic processing of amyloid precursor protein in a mouse model of Alzheimer's disease.慢性给予抗中风草药通络救脑可减少阿尔茨海默病小鼠模型中淀粉样前体蛋白的淀粉样形成过程。
PLoS One. 2013;8(3):e58181. doi: 10.1371/journal.pone.0058181. Epub 2013 Mar 5.
2
Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer's disease.沙利度胺通过抑制阿尔茨海默病小鼠模型中的β-分泌酶改善淀粉样蛋白样病理。
PLoS One. 2013;8(2):e55091. doi: 10.1371/journal.pone.0055091. Epub 2013 Feb 6.
3
β-secretase cleavage of the fly amyloid precursor protein is required for glial survival.β-分泌酶对果蝇淀粉样前体蛋白的切割对于神经胶质细胞的存活是必需的。
J Neurosci. 2012 Nov 14;32(46):16181-92. doi: 10.1523/JNEUROSCI.0228-12.2012.
4
Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease.细胞表面淀粉样前体蛋白交联导致海马神经元中β-淀粉样肽生成增加:对阿尔茨海默病的影响。
J Neurosci. 2012 Aug 1;32(31):10674-85. doi: 10.1523/JNEUROSCI.6473-11.2012.
5
Depletion of GGA1 and GGA3 mediates postinjury elevation of BACE1.耗竭 GGAl 和 GGAs3 介导损伤后 BACE1 的升高。
J Neurosci. 2012 Jul 25;32(30):10423-37. doi: 10.1523/JNEUROSCI.5491-11.2012.
6
The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo.神经细胞黏附分子 L1 和 CHL1 可被体内 BACE1 蛋白酶切割。
J Biol Chem. 2012 Jul 27;287(31):25927-40. doi: 10.1074/jbc.M112.377465. Epub 2012 Jun 12.
7
Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation.可溶性淀粉样前体蛋白-α调节β-分泌酶活性和淀粉样-β生成。
Nat Commun. 2012 Apr 10;3:777. doi: 10.1038/ncomms1781.
8
Lys(203) and Lys(382) are essential for the proteasomal degradation of BACE1.Lys(203) 和 Lys(382) 对于 BACE1 的蛋白酶体降解是必需的。
Curr Alzheimer Res. 2012 Jun;9(5):606-15. doi: 10.2174/156720512800618026.
9
Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease.Cdk5 蛋白抑制和 Aβ42 通过转录后机制增加原代神经元中的 BACE1 蛋白水平:CDK5 作为阿尔茨海默病治疗靶点的意义。
J Biol Chem. 2012 Mar 2;287(10):7224-35. doi: 10.1074/jbc.M111.333914. Epub 2012 Jan 5.
10
Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.泛素羧基末端水解酶 L1 对 BACE1 降解和 APP 加工的调控。
J Neurochem. 2012 Mar;120(6):1129-38. doi: 10.1111/j.1471-4159.2011.07644.x. Epub 2012 Feb 10.

β-分泌酶:作为疾病治疗靶点的生物学特性。

β-Secretase: its biology as a therapeutic target in diseases.

机构信息

Center for Advanced Therapeutic Strategies for Brain Disorders, Roskamp Institute, Sarasota, FL 34203, USA.

出版信息

Trends Pharmacol Sci. 2013 Apr;34(4):215-25. doi: 10.1016/j.tips.2013.01.008. Epub 2013 Feb 27.

DOI:10.1016/j.tips.2013.01.008
PMID:23452816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3691103/
Abstract

β-Secretase (BACE1, β-site APP cleaving enzyme 1) is an aspartic proteinase that has multiple functions in various physiological processes, such as cell differentiation, immunoregulation, and cell death. There is increasing evidence that changes in BACE1 activity are involved in many diseases, such as Alzheimer's disease (AD), schizophrenia, epileptic behavior, and others. However, a deeper understanding of the molecular biology of BACE1 is necessary for further exploration of cell development, immunological regulation, and disease pathogenesis. Here, we review the molecular and cellular biology of BACE1, including its enzymatic properties, structure, biosynthesis, and physiological functions to provide a new perspective and rational assessment of drugability. Lastly, we discuss proposed strategies to control BACE1 activity for possible therapeutic application.

摘要

β-分泌酶(BACE1,β 位淀粉样前体蛋白裂解酶 1)是一种天冬氨酸蛋白酶,在多种生理过程中具有多种功能,如细胞分化、免疫调节和细胞死亡。越来越多的证据表明,BACE1 活性的变化与许多疾病有关,如阿尔茨海默病(AD)、精神分裂症、癫痫行为等。然而,为了进一步探索细胞发育、免疫调节和疾病发病机制,需要更深入地了解 BACE1 的分子生物学。在这里,我们综述了 BACE1 的分子和细胞生物学,包括其酶学特性、结构、生物合成和生理功能,为药物开发提供了新的视角和合理的评估。最后,我们讨论了控制 BACE1 活性的可能治疗应用的策略。